Shares of the company are trading at $388.63 which is a tad above the 50 day moving average of $365.20 and which is slightly above the 200 day moving average of $369.72. Capital Insight Partners LLC's holdings in Amerco were worth $922,000 as of its most recent SEC filing.
Several other large investors have also added to or reduced their stakes in the company.
Skylands Capital Llc increased Amerco (UHAL) stake by 4.26% reported in 2016Q4 SEC filing. Bruce & Co Inc sold 1,545 shares as the company's stock declined 0.39% while stock markets rallied. Finally, Reinhart Partners Inc. bought a new stake in Amerco during the first quarter valued at $18,423,000. State Street Corp raised its stake in Amerco by 9.6% in the fourth quarter. Guggenheim Capital LLC now owns 3,661 shares of the transportation company's stock worth $1,353,000 after buying an additional 915 shares in the last quarter. Tredje AP fonden increased its stake in shares of Amerco by 2.4% in the second quarter. Principal Financial Group Inc. now owns 176,953 shares of the transportation company's stock worth $67,453,000 after buying an additional 176,239 shares in the last quarter. The institutional investor held 191,570 shares of the rental and leasing company at the end of 2016Q4, valued at $70.80M, down from 193,115 at the end of the previous reported quarter.
The company is trading unchanged by 0.00 percent from yesterday's close. The firm has a market cap of $7.62 billion, a price-to-earnings ratio of 19.10 and a beta of 1.10. Amerco has a 1-year low of $307.80 and a 1-year high of $398.94. The company's 50-day moving average price is $370.17 and its 200 day moving average price is $370.16.
Amerco (NASDAQ:UHAL) last released its quarterly earnings results on Wednesday, August 9th. The business had revenue of $708.80 million for the quarter, compared to analyst estimates of $702.54 million. Amerco had a net margin of 10.92% and a return on equity of 13.00%. The firm's revenue for the quarter was up 3.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.68 earnings per share. On average, equities research analysts expect that Amerco will post $22.00 earnings per share for the current fiscal year.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Stock Rating Reaffirmed by BMO Capital Markets
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Wellington Management Group LLP increased its stake in shares of Ionis Pharmaceuticals by 56.1% in the first quarter.
The company also recently declared a special dividend, which was paid on Thursday, August 3rd. Stockholders of record on Thursday, July 20th were paid a dividend of $1.00 per share. The ex-dividend date of this dividend was Tuesday, July 18th.
COPYRIGHT VIOLATION WARNING: "Amerco (NASDAQ:UHAL) Receiving Somewhat Favorable News Coverage, Study Finds" was reported by BBNS and is owned by of BBNS. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of United States and worldwide trademark and copyright laws. The original version of this piece of content can be read at https://baseballnewssource.com/markets/amerco-nasdaquhal-receiving-somewhat-favorable-news-coverage-study-finds/1439108.html.
Separately, BidaskClub cut Amerco from a "buy" rating to a "hold" rating in a research note on Thursday, June 22nd.
In other news, major shareholder Grove Holdings Lp Willow acquired 2,000 shares of the stock in a transaction that occurred on Tuesday, May 30th. Following the completion of the purchase, the insider now directly owns 7,562,884 shares of the company's stock, valued at $2,668,714,877.08. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.